Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
1 , 15018 (2015) K.R
J Leukoc Biol 66:411415
Therapeutic potential of GLP-1RAs in sleep apnea with genetic associations to type 2 diabetes
Summary: GLP-1 receptor agonists are not licensed for anxiety treatment and lack established evidence for direct anxiolytic effects, though some patients may experience secondary psychological improvements through metabolic health gains
doi: 10.1080/00325481.2019.1581971 52 JiangFYangJZhangYDongMWangSZhangQet al
Clear documentation and informed consent are essential for off-label dual therapy
US$ 26.68
US$ 21.74
US$ 23.56
US$ 20.41
US$ 20.56
